Search research articles
Contact Us
Filters
Showing results (21-30 of 82) with videos related to
Page
of 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 25, 2025
Nanobody-enhanced T cell cancer immunotherapy: Advancing precision medicine
Remy Boisgard, Juliette Prothon, Celia Torrielli, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 12, 2008
Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy
Ralph Willemsen, Patrick Chames, Erik Schooten, et al.
Molecular Biosystems
|
July 10, 2012
Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches
Klervi Even-Desrumeaux, Patrick Fourquet, Véronique Secq, et al.
Human Immunology
|
January 1, 2003
Genetic engineering of T cell specificity for immunotherapy of cancer
Ralph A Willemsen, Reno Debets, Patrick Chames, et al.
ACS Nano
|
January 21, 2015
Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers
Damien Nevoltris, Benjamin Lombard, Elodie Dupuis, et al.
Biophysical Journal
|
April 14, 2019
Nanobody-CD16 Catch Bond Reveals NK Cell Mechanosensitivity
Cristina González, Patrick Chames, Brigitte Kerfelec, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 24, 2026
Optimizing nanobody-based molecules targeting mesothelin: Exploring format, valency, size, and half-life for next-generation cancer theranostics
Remy Boisgard, Darcy MacFarland, Armelle Goubard, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 10, 2005
T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production
Ralph A Willemsen, Cees Ronteltap, Patrick Chames, et al.
Nucleic Acids Research
|
November 25, 2005
In vivo selection of engineered homing endonucleases using double-strand break induced homologous recombination
Patrick Chames, Jean-Charles Epinat, Sophie Guillier, et al.
Journal of Biomedical Nanotechnology
|
August 27, 2015
Anti-Mesothelin Nanobodies for Both Conventional and Nanoparticle-Based Biomedical Applications
Andrew M Prantner, Marc Turini, Brigitte Kerfelec, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 82) with videos related to
Sort By:
Page
of 9
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 25, 2025
Nanobody-enhanced T cell cancer immunotherapy: Advancing precision medicine
Remy Boisgard, Juliette Prothon, Celia Torrielli, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 12, 2008
Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy
Ralph Willemsen, Patrick Chames, Erik Schooten, et al.
Molecular Biosystems
|
July 10, 2012
Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches
Klervi Even-Desrumeaux, Patrick Fourquet, Véronique Secq, et al.
Human Immunology
|
January 1, 2003
Genetic engineering of T cell specificity for immunotherapy of cancer
Ralph A Willemsen, Reno Debets, Patrick Chames, et al.
ACS Nano
|
January 21, 2015
Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers
Damien Nevoltris, Benjamin Lombard, Elodie Dupuis, et al.
Biophysical Journal
|
April 14, 2019
Nanobody-CD16 Catch Bond Reveals NK Cell Mechanosensitivity
Cristina González, Patrick Chames, Brigitte Kerfelec, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 24, 2026
Optimizing nanobody-based molecules targeting mesothelin: Exploring format, valency, size, and half-life for next-generation cancer theranostics
Remy Boisgard, Darcy MacFarland, Armelle Goubard, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 10, 2005
T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production
Ralph A Willemsen, Cees Ronteltap, Patrick Chames, et al.
Nucleic Acids Research
|
November 25, 2005
In vivo selection of engineered homing endonucleases using double-strand break induced homologous recombination
Patrick Chames, Jean-Charles Epinat, Sophie Guillier, et al.
Journal of Biomedical Nanotechnology
|
August 27, 2015
Anti-Mesothelin Nanobodies for Both Conventional and Nanoparticle-Based Biomedical Applications
Andrew M Prantner, Marc Turini, Brigitte Kerfelec, et al.
Page
of 9